Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-010007

CHIEF MEDICAL OFFICER gave up 991 shares (to pay taxes)

  • CHIEF MEDICAL OFFICER acquired 3,374 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Paolini John F. CHIEF MEDICAL OFFICER 2025-04-01 Option exercise +1,624 54,880 D
Paolini John F. CHIEF MEDICAL OFFICER 2025-04-01 Option exercise +1,750 56,630 D
Paolini John F. CHIEF MEDICAL OFFICER 2025-04-01 Shares withheld for taxes −477 $21.77 $10,384 56,153 D
Paolini John F. CHIEF MEDICAL OFFICER 2025-04-01 Shares withheld for taxes −514 $21.77 $11,190 55,639 D
Derivatives
Paolini John F. CHIEF MEDICAL OFFICER 2025-04-01 Grant or award · Share Option +39,364 39,364 D
Paolini John F. CHIEF MEDICAL OFFICER 2025-04-01 Grant or award · Restricted Share Unit +9,828 9,828 D
Paolini John F. CHIEF MEDICAL OFFICER 2025-04-01 Grant or award · Performance Share Unit +19,657 19,657 D
Paolini John F. CHIEF MEDICAL OFFICER 2025-04-01 Option exercise · Restricted Share Unit −1,624 3,248 D
Paolini John F. CHIEF MEDICAL OFFICER 2025-04-01 Option exercise · Restricted Share Unit −1,750 5,250 D
Loading xslF345X05/form4-04032025_090458.xml…